Sunday, April 10, 2011

Disease modifying anti-rheumatic agents

Disease modifying anti-rheumatic drugs (DMARDs) or slow acting anti-rheumatic drugs (SAARDs)

1. Slow the course of the disease and can induce remission.

2. Reduce or prevent the joint damage.

Drugs to be choosen:
Many experts start therapy with the conventional drugs i.e. methotrexate or hydroxychloroquine. But if these do not work properly then they go to the newer agents i.e. anakinra, adalimumab, leflunomide, and infliximab. Often it is also prescribed that the combination therapy is more effective.
Post a Comment